Hoxton Planning & Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,250
Closed -$215K 220
2025
Q4
$215K Buy
2,250
+44
+2% +$4.31K 0.06% 205
2025
Q3
$215K Sell
2,206
-43
-2% -$4.45K 0.07% 204
2025
Q2
$242K Buy
2,249
+64
+3% +$6.48K 0.08% 178
2025
Q1
$220K Buy
+2,185
New +$220K 0.08% 182

Other funds holding BSX

Hoxton Planning & Management's BSX Position: Q1 2026 in Review

Hoxton Planning & Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,250 shares — an estimated $215K sold.

Hoxton Planning & Management first reported a position in BSX in Q1 2025 and held it in 4 quarters. The position peaked at $242K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Hoxton Planning & Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Hoxton Planning & Management sold 2,250 Boston Scientific shares in Q1 2026, an estimated $215K.
  • Hoxton Planning & Management first reported a position in Boston Scientific in Q1 2025 and held it in 4 quarters.
  • Hoxton Planning & Management's Boston Scientific position peaked at $242K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Hoxton Planning & Management's 13F filing for Q1 2026, filed 20 Apr 2026.